Prevention and Treatment of Atherosclerosis

Improving State-of-the-Art Management and Search for Novel Targets

AvArnold von Eckardstein,Christoph J. Binder

Inbunden, Engelska, 2022

Del 270 i serien Handbook of Experimental Pharmacology

559 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.

Produktinformation

Utgivningsdatum:2022-02-01
Mått:155 x 235 x 33 mm
Vikt:1 080 g
Format:Inbunden
Språk:Engelska
Serie:Handbook of Experimental Pharmacology
Antal sidor:538
Förlag:Springer Nature Switzerland AG
ISBN:9783030860752

Utforska kategorier

Farmakologi inom Medicin
Sjukdomar och rubbningar inom Medicin
Klinisk medicin och internmedicin inom Medicin

Mer om författaren

Previous publications in the Handbook of Experimental Pharmacology series co-edited by Prof. Arnold von Eckardstein : Atherosclerosis: Diet and Drugs, 2005, Arnold von Eckardstein; High Density Lipoproteins, 2015, Arnold von Eckardstein, Dimitris Kardassis (eds.), Open Access

Innehållsförteckning

Diet, Life Style, Smoking.- Blood Pressure Lowering.- Glycemic Control in Diabetes.- LDL-Cholesterol Lowering.- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation).- Triglyceride Rich Lipoproteins.- HDL.- Lipoprotein(a).- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome.- Nutraceuticals / Functional Food.- Adipose Tissue (WAT, BAT).- Microbiota and Cardiometabolic Disease.- SMCs, Matrix.- Immune Modulation.- NETs and Neutrophils.- Genomic Strategies Towards Identification of Novel Therapeutic Targets.- Non Coding RNAs.- Metabolomics, Lipidomics.- Epigenomics.